Article ID Journal Published Year Pages File Type
2543628 Journal of the American Pharmacists Association 2009 6 Pages PDF
Abstract
These results support community pharmacy assertions of lower reimbursements from Part D payers compared with Medicaid payers. Based on these results, pharmacies can respond to this evolving environment by carefully reviewing their Part D plans' impact on CPGM and taking available steps to increase the proportion of generic drugs dispensed to Medicare beneficiaries.
Related Topics
Health Sciences Medicine and Dentistry Public Health and Health Policy
Authors
, , , ,